Skip to main content
. 2016 Feb 5;11(2):e0148489. doi: 10.1371/journal.pone.0148489

Table 3. ARIMA modelling outcomes for three Dutch smoking cessation policies of RSV data from the Netherlands and Belgium (corrected for Belgian interventions).

The Netherlands Belgium (control group)
  Period Estimated ratio of change in RSV 95% CI Estimated ratio of change in RSV 95% CI
Smoking ban restaurants and bars 2008
Weeks before intervention 9–16 0.98 (0.89–1.07) 1.01 (0.90–1.12)
5–8 0.95 (0.84–1.07) 1.03 (0.91–1.18)
3–4 0.99 (0.86–1.13) 0.99 (0.84–1.15)
2 1.02 (0.87–1.18) 0.98 (0.82–1.19)
1 0.97 (0.83–1.14) 1.05 (0.87–1.27)
Weeks after intervention 1 1.21* (1.04–1.42) 1.01 (0.84–1.22)
2 1.41* (1.21–1.64) 1.07 (0.89–1.29)
3–4 1.25* (1.08–1.43) 0.95 (0.81–1.13)
5–8 1.08 (0.96–1.22) 1.02 (0.88–1.18)
9–16 1.04 (0.94–1.15) 0.96 (0.84–1.10)
17–32 0.99 (0.91–1.08) 0.91 (0.81–1.02)
33–52 0.99 (0.92–1.07) 0.95 (0.86–1.05)
Reimbursement SCS 2011
Weeks before intervention 9–16 0.98 (0.89–1.07) 1.09 (0.98–1.20)
5–8 1.06 (0.94–1.20) 1.25* (1.09–1.43)
3–4 0.94 (0.82–1.08) 1.05 (0.89–1.22)
2 1.00 (0.86–1.16) 1.10 (0.92–1.32)
1 1.07 (0.89–1.21) 0.83 (0.69–1.00)
Weeks after intervention 1 1.04 (0.85–1.17) 0.86 (0.71–1.04)
2 0.98 (0.84–1.14) 1.10 (0.91–1.32)
3–4 1.16* (1.01–1.33) 1.26* (1.07–1.48)
5–8 1.21* (1.08–1.37) 1.19* (1.03–1.38)
9–16 1.18* (1.06–1.30) 1.20* (1.04–1.35)
17–32 1.22* (1.13–1.33) 0.95 (0.81–1.10)
33–52 1.20* (1.13–1.33) 0.99 (0.89–1.09)
Reimbursement SCS 2013
Weeks before intervention 9–16 1.03 (0.94–1.13) 0.86* (0.76–0.97)
5–8 1.01 (0.90–1.14) 0.84* (0.70–0.98)
3–4 1.02 (0.89–1.17) 0.87 (0.70–1.04)
2 0.98 (0.84–1.14) 0.94 (0.75–1.14)
1 1.03 (0.88–1.21) 0.89 (0.69–1.09)
Weeks after intervention 1 0.85* (0.72–0.99) 0.80* (0.66–0.98)
2 0.99 (0.85–1.15) 1.01 (0.82–1.23)
3–4 1.17* (1.02–1.34) 0.89 (0.74–1.27)
5–8 1.14* (1.01–1.29) 0.88 (0.74–1.05)
9–16 1.21* (1.09–1.33) 0.91 (0.76–1.08)
17–32 1.09* (1.00–1.19) 0.96 (0.79–1.16)
33–52 1.08 (1.00–1.18) 0.95 (0.77–1.17)

CI: confidence interval

* Significant at P<0.05.